Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
BIIB076 NI-105,
6C5 huIgG1/l
Alzheimer's Disease (Discontinued) Biogen, Eisai Co., Ltd., Neurimmune Tau Immunotherapy (passive)
Davunetide NAP,
AL-108
Mild Cognitive Impairment (Discontinued), Progressive Supranuclear Palsy (Discontinued), Schizophrenia (Discontinued), Frontotemporal Dementia (Inactive) Allon Therapeutics Inc., Paladin Labs Inc. Tau Other
Epothilone D BMS-241027 Alzheimer's Disease (Discontinued) Bristol-Myers Squibb Tau Small Molecule
Gosuranemab BIIB092,
BMS-986168, IPN007
Progressive Supranuclear Palsy (Discontinued), Alzheimer's Disease (Discontinued) Biogen, Bristol-Myers Squibb Tau Immunotherapy (passive)
Rember TM Methylene Blue ,
methylthioninium (MT),
TRx-0014,
Tau aggregation inhibitor (TAI)
Alzheimer's Disease (Discontinued) TauRx Therapeutics Ltd Tau Small Molecule Methylene Blue predates FDA. Used for treatment of malaria and methemoglobinemia.
RG7345 RO6926496 Alzheimer's Disease (Discontinued) Tau Immunotherapy (passive)
Tideglusib NP031112,
Nypta® ,
Zentylor™ ,
Glycogen synthase kinase 3 inhibitor,
NP12
Alzheimer's Disease (Discontinued), Progressive Supranuclear Palsy (Discontinued) Zeltia Group Tau Small Molecule
Tilavonemab ABBV-8E12,
C2N 8E12,
HJ8.5
Progressive Supranuclear Palsy (Discontinued), Alzheimer's Disease (Discontinued) AbbVie, C2N Diagnostics, LLC Tau Immunotherapy (passive)
Zagotenemab LY3303560 Alzheimer's Disease (Discontinued) Eli Lilly & Co. Tau, Unknown Immunotherapy (passive)